SE505239C2 - Nya 2-karbonyl-substituerade N,N'-di- (trimetoxybensoyl) piperaziner, förfarande för framställning därav samt terapeutiska kompositioner innehållande dessa - Google Patents

Nya 2-karbonyl-substituerade N,N'-di- (trimetoxybensoyl) piperaziner, förfarande för framställning därav samt terapeutiska kompositioner innehållande dessa

Info

Publication number
SE505239C2
SE505239C2 SE8903312A SE8903312A SE505239C2 SE 505239 C2 SE505239 C2 SE 505239C2 SE 8903312 A SE8903312 A SE 8903312A SE 8903312 A SE8903312 A SE 8903312A SE 505239 C2 SE505239 C2 SE 505239C2
Authority
SE
Sweden
Prior art keywords
general formula
substituent
carbon atoms
piperazine
group
Prior art date
Application number
SE8903312A
Other languages
English (en)
Swedish (sv)
Other versions
SE8903312L (sv
SE8903312D0 (sv
Inventor
Eduardo Pirotsky
George Dive
Jean-Jacques Godfroid
Francoise Heymans
Pierre Braquet
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of SE8903312D0 publication Critical patent/SE8903312D0/xx
Publication of SE8903312L publication Critical patent/SE8903312L/xx
Publication of SE505239C2 publication Critical patent/SE505239C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8903312A 1988-10-11 1989-10-09 Nya 2-karbonyl-substituerade N,N'-di- (trimetoxybensoyl) piperaziner, förfarande för framställning därav samt terapeutiska kompositioner innehållande dessa SE505239C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888823775A GB8823775D0 (en) 1988-10-11 1988-10-11 New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines

Publications (3)

Publication Number Publication Date
SE8903312D0 SE8903312D0 (sv) 1989-10-09
SE8903312L SE8903312L (sv) 1990-04-12
SE505239C2 true SE505239C2 (sv) 1997-07-21

Family

ID=10644988

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8903312A SE505239C2 (sv) 1988-10-11 1989-10-09 Nya 2-karbonyl-substituerade N,N'-di- (trimetoxybensoyl) piperaziner, förfarande för framställning därav samt terapeutiska kompositioner innehållande dessa

Country Status (33)

Country Link
US (1) US4923870A (fr)
JP (1) JPH0635452B2 (fr)
KR (1) KR970004912B1 (fr)
AR (1) AR245110A1 (fr)
AT (1) AT395423B (fr)
AU (1) AU618220B2 (fr)
BE (1) BE1003519A3 (fr)
CA (1) CA1320958C (fr)
CH (1) CH679859A5 (fr)
DE (1) DE3933881C2 (fr)
DK (1) DK500389A (fr)
DZ (1) DZ1365A1 (fr)
ES (1) ES2018403A6 (fr)
FI (1) FI96854C (fr)
FR (2) FR2637500B1 (fr)
GB (2) GB8823775D0 (fr)
GR (1) GR1000343B (fr)
HK (1) HK47592A (fr)
IE (1) IE62011B1 (fr)
IN (1) IN173325B (fr)
IT (1) IT1237088B (fr)
LU (1) LU87604A1 (fr)
MA (1) MA21652A1 (fr)
MY (1) MY106235A (fr)
NL (1) NL8902520A (fr)
NO (1) NO176180C (fr)
NZ (1) NZ230927A (fr)
OA (1) OA09139A (fr)
PT (1) PT91941B (fr)
SE (1) SE505239C2 (fr)
SG (1) SG41292G (fr)
TN (1) TNSN89110A1 (fr)
ZA (1) ZA897554B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
GB8908587D0 (en) * 1989-04-15 1989-06-01 Scras Societe De Conseils De R New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
WO1992020661A1 (fr) * 1991-05-22 1992-11-26 Merck & Co., Inc. N, n-diacylpiperazines
US5344830A (en) * 1992-12-10 1994-09-06 Merck & Co., Inc. N,N-diacylpiperazine tachykinin antagonists
US5348955A (en) * 1993-06-22 1994-09-20 Merck & Co., Inc. N,N-diacylpiperazines
FR2780649B1 (fr) 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3186993A (en) * 1962-06-07 1965-06-01 Ethyl Corp alpha, alpha'-(1, 4-piperazinediyl) bis (3, 5-dialkyl-4-hydroxythiobenzaldehyde) compounds
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
DE2423847A1 (de) * 1973-05-28 1975-01-02 Ciba Geigy Ag Neue sulfamoylbenzoesaeureamide
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
DE3636278A1 (de) * 1986-10-24 1988-05-05 Hoechst Ag Herbizide mittel auf der basis von cyclischen (alpha)-iminocarbon-saeureaniliden sowie neue (alpha)-iminocarbonsaeureanilide und verfahren zu ihrer herstellung
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
NO894038L (no) 1990-04-17
NO894038D0 (no) 1989-10-10
MY106235A (en) 1995-04-29
IN173325B (fr) 1994-04-02
DE3933881A1 (de) 1990-04-12
OA09139A (fr) 1991-10-31
HK47592A (en) 1992-07-10
GR1000343B (el) 1992-06-25
ZA897554B (en) 1990-07-25
FR2637500A1 (fr) 1990-04-13
IT8921992A1 (it) 1991-04-11
JPH02223565A (ja) 1990-09-05
IT1237088B (it) 1993-05-18
FI894812A0 (fi) 1989-10-11
FI96854C (fi) 1996-09-10
MA21652A1 (fr) 1990-07-01
BE1003519A3 (fr) 1992-04-14
NZ230927A (en) 1991-01-29
DK500389A (da) 1990-04-12
CH679859A5 (fr) 1992-04-30
PT91941A (pt) 1990-04-30
CA1320958C (fr) 1993-08-03
IE62011B1 (en) 1994-12-14
FR2637593A1 (fr) 1990-04-13
IE893258L (en) 1990-04-11
JPH0635452B2 (ja) 1994-05-11
ATA234689A (de) 1992-05-15
SE8903312L (sv) 1990-04-12
PT91941B (pt) 1995-05-31
US4923870A (en) 1990-05-08
FI894812A (fi) 1990-04-12
LU87604A1 (fr) 1990-02-07
AU4268889A (en) 1990-04-26
FR2637500B1 (fr) 1992-06-05
ES2018403A6 (es) 1991-04-01
TNSN89110A1 (fr) 1991-02-04
GB2223753B (en) 1992-01-02
DZ1365A1 (fr) 2004-09-13
KR970004912B1 (ko) 1997-04-08
FI96854B (fi) 1996-05-31
SE8903312D0 (sv) 1989-10-09
AT395423B (de) 1992-12-28
GB2223753A (en) 1990-04-18
GB8922870D0 (en) 1989-11-29
FR2637593B1 (fr) 1992-06-05
SG41292G (en) 1992-06-12
NL8902520A (nl) 1990-05-01
AR245110A1 (es) 1993-12-30
KR900006309A (ko) 1990-05-07
DK500389D0 (da) 1989-10-10
GR890100647A (en) 1990-11-29
GB8823775D0 (en) 1988-11-16
NO176180B (no) 1994-11-07
NO176180C (no) 1995-02-15
AU618220B2 (en) 1991-12-12
DE3933881C2 (de) 1994-06-30
IT8921992A0 (it) 1989-10-11

Similar Documents

Publication Publication Date Title
JP2022174114A (ja) Ａｌｋタンパク質分解剤及びそれらの癌療法における使用
DE69111619T2 (de) 1,4-benzothiazedinderivat.
DE69202876T2 (de) Inhibitoren von N-Myristoyltransferase, deren Verfahren zur Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen.
US20150274679A1 (en) Substituted 1,5-benzodiazepinones compounds
AU2022258377A1 (en) Ring-modified proline short peptide compound and use thereof
EP0157609A2 (fr) Dérivés de lipide, leur production et utilisation
SE505239C2 (sv) Nya 2-karbonyl-substituerade N,N'-di- (trimetoxybensoyl) piperaziner, förfarande för framställning därav samt terapeutiska kompositioner innehållande dessa
SU1318161A3 (ru) Способ получени пиперазиновых производных или их фармацевтически приемлемых солей (его варианты)
JPS5896075A (ja) １−アミノカルボニルエチル置換ピペラジン及びホモピペラジン誘導体
CA1319692C (fr) N,n'-di-(trimethoxybenzoyl)pyperazines substituees par un groupe 2-methoxycarbonyle, procede pour sa preparation et composes therapeutiques en contenant
CN113429396A (zh) 一种五元杂芳环衍生物及其制备方法和用途
FR2516510A1 (fr) Derives de la (trimethoxy-3,4,5-cinnamoyl)-1-aminocarbonylethyl-4-piperazine substituee utilisables en pharmacie et procede pour leur preparation
JPS63225354A (ja) アゼチジノン誘導体
EP4357346A1 (fr) Anti-inflammatoire externe couplant un composé et un médicament, son procédé de préparation et son utilisation
CN118420619A (zh) 一类靶向蛋白降解的化合物及其制备方法和应用

Legal Events

Date Code Title Description
NUG Patent has lapsed